Call for Networks to join ACT 2 Grant Application

To enhance the impact of trial networks in Canada, ACT is holding a call for networks to join the ACT-2 grant application. Within the proposal, we aim to provide financial support to approximately 40 new or existing trial networks, networks also have the opportunity to be affiliated with ACT-2 without funding.

For an application to be eligible the Canadian network must have: 10+ researchers, representation in 5+ provinces/territories, and 5+ sites.

Application deadline: February 2nd, 2026, noon ET

Full details of the call are available at: https://act-aec.ca/call-for-networks/

Twitter Youtube Linkedin

KM RFA Announcement

June 6, 2025 No Comments

The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices. Knowledge mobilization is a key

Read More »

RFA 5 Announcement

November 22, 2024 No Comments

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were initiated and are led by

Read More »

Canadian Biotech Opportunity

July 16, 2024 No Comments

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies

Read More »

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.